Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 12:48 PM
Ignite Modification Date: 2025-12-25 @ 12:15 PM
NCT ID: NCT01021761
Description: None
Frequency Threshold: 1
Time Frame: None
Study: NCT01021761
Study Brief: A Comparison of Prostaglandin E2 (PGE2) Inhibition of Acuvail(Ketorolac 0.45%), Xibrom (Bromfenac 0.09%)and Nevanac (Nepafenac)in Patients Undergoing Phacoemulsification
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Xibrom Xibrom to be given 1 drop BID the day before surgery and 3 doses pre op the day of surgery prior to surgery None None 0 42 0 42 View
Acuvail Acuvail to be given preoperatively. One drop BID, 1 day pre op and day of surgery 3 doses prior to surgery. None None 0 42 0 42 View
Nevanac Nevanac to be given 1 drop BID the day before surgery and 3 doses pre op the day of surgery prior to surgery None None 0 42 0 42 View
Serious Events(If Any):
Other Events(If Any):